B

Braidwell Portfolio holdings

AUM $3B
1-Year Est. Return 46.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+46.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3B
AUM Growth
-$129M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
104
New
Increased
Reduced
Closed

Top Buys

1 +$56.7M
2 +$50.2M
3 +$43.9M
4
GLUE icon
Monte Rosa Therapeutics
GLUE
+$43.2M
5
ARGX icon
argenx
ARGX
+$42.2M

Top Sells

1 +$82.6M
2 +$59.5M
3 +$50.2M
4
RAPT
RAPT Therapeutics
RAPT
+$31.5M
5
LEGN icon
Legend Biotech
LEGN
+$28.2M

Sector Composition

1 Healthcare 87.27%
2 Financials 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOA
51
BioAge Labs
BIOA
$769M
$21M 0.7%
+1,200,587
CVS icon
52
CVS Health
CVS
$116B
$20.9M 0.7%
290,700
-273,500
TARS icon
53
Tarsus Pharmaceuticals
TARS
$2.56B
$18.6M 0.62%
+265,715
ELV icon
54
Elevance Health
ELV
$85.4B
$18.2M 0.61%
+62,080
KIDS icon
55
OrthoPediatrics
KIDS
$441M
$17.5M 0.58%
1,100,370
ENGN icon
56
enGene Therapeutics
ENGN
$124M
$16.7M 0.56%
2,456,870
-674,449
NKTR icon
57
Nektar Therapeutics
NKTR
$2.19B
$16M 0.53%
+222,701
ACHC icon
58
Acadia Healthcare
ACHC
$2.13B
$15.1M 0.5%
+645,900
ORIC icon
59
Oric Pharmaceuticals
ORIC
$875M
$14.3M 0.48%
+1,128,040
AVAH icon
60
Aveanna Healthcare
AVAH
$1.56B
$14.2M 0.47%
+2,203,506
XFOR icon
61
X4 Pharmaceuticals
XFOR
$407M
$13.5M 0.45%
3,272,954
-95,950
KNSA icon
62
Kiniksa Pharmaceuticals
KNSA
$3.72B
$13.1M 0.44%
272,522
-41,301
EOLS icon
63
Evolus
EOLS
$432M
$12.8M 0.43%
3,105,209
TGTX icon
64
TG Therapeutics
TGTX
$5.81B
$11.9M 0.4%
+358,800
SRZN icon
65
Surrozen
SRZN
$304M
$11.5M 0.38%
396,100
-73,900
CNC icon
66
Centene
CNC
$29.4B
$10.8M 0.36%
+330,000
CLYM
67
Climb Bio
CLYM
$628M
$10.5M 0.35%
+1,529,675
CMPX icon
68
Compass Therapeutics
CMPX
$429M
$10.4M 0.35%
1,965,106
-821,672
IONS icon
69
Ionis Pharmaceuticals
IONS
$12.6B
$9.83M 0.33%
+130,862
HLXC
70
Helix Acquisition Corp III
HLXC
$225M
$9.27M 0.31%
+900,000
VOR icon
71
Vor Biopharma
VOR
$811M
$8.33M 0.28%
+466,774
RVMD icon
72
Revolution Medicines
RVMD
$33.5B
$8.26M 0.28%
+84,900
GRAL
73
GRAIL Inc
GRAL
$3.08B
$7.38M 0.25%
142,755
ACRS icon
74
Aclaris Therapeutics
ACRS
$635M
$6.37M 0.21%
+1,699,116
DNLI icon
75
Denali Therapeutics
DNLI
$3.34B
$5.69M 0.19%
+296,324